Cargando…
Cost-Effectiveness Analysis of Triple Combination Preparations in the Treatment of Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Objectives: This study analyzed the long-term cost-effectiveness of fluticasone/umeclidinium/vilanterol triple combination (FF/UMEC/VI) vs. budesonide/formoterol double combination (BUD/FOR) in the treatment of moderate-to-severe chronic obstructive pulmonary disease (COPD) and provides evidence for...
Autores principales: | Zhou, Yikang, Long, Enwu, Xu, Qian, Wang, Lei, Jiang, Xuehua, Hu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355539/ https://www.ncbi.nlm.nih.gov/pubmed/34395374 http://dx.doi.org/10.3389/fpubh.2021.713258 |
Ejemplares similares
-
Assessment of Health-Related Quality of Life Using EuroQoL-5 Dimension in Populations With Prediabetes, Diabetes, and Normal Glycemic Levels in Southwest China
por: Long, Enwu, et al.
Publicado: (2021) -
Patient experience with chronic obstructive pulmonary disease: a nationally representative demonstration study on quality and cost of healthcare services
por: Ghamari, Seyyed-Hadi, et al.
Publicado: (2023) -
Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China
por: Zhou, Ting, et al.
Publicado: (2021) -
Investigating the relationships among lung function variables in chronic obstructive pulmonary disease in men
por: Chuang, Ming-Lung, et al.
Publicado: (2019) -
Assessing volatile organic compounds exposure and chronic obstructive pulmonary diseases in US adults
por: Lv, Jia-jie, et al.
Publicado: (2023)